Columbia Nephrology
Columbia, South Carolina 29203
1 studies enrolling now · 2 studies all time
What they study most
Chronic Kidney Disease, End Stage Kidney Disease
Studies at this site
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
- Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria — Completed